- Release Date: 09/02/23 08:16
- Summary: Preclinical Data Shows ARG007 Inhibits a Cause of Alzheimers
- Price Sensitive: Yes
- Download Document 360.51KB
- Forums
- ASX - By Stock
- Ann: Preclinical Data Shows ARG007 Inhibits a Cause of Alzheimers
Ann: Preclinical Data Shows ARG007 Inhibits a Cause of Alzheimers
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
|
|||||
Last
82.0¢ |
Change
0.065(8.61%) |
Mkt cap ! $101.4M |
Open | High | Low | Value | Volume |
76.0¢ | 84.5¢ | 76.0¢ | $204.5K | 254.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 41111 | 82.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
83.5¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 46111 | 0.820 |
1 | 5000 | 0.815 |
2 | 8750 | 0.800 |
1 | 1000 | 0.790 |
1 | 20001 | 0.785 |
Price($) | Vol. | No. |
---|---|---|
0.835 | 5000 | 1 |
0.840 | 5000 | 1 |
0.850 | 15000 | 1 |
0.855 | 10000 | 1 |
0.860 | 13500 | 1 |
Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online